|
|
|
Axxam is the proud recipient of numerous grants and awards from government agencies that recognize our contribution to technological innovation. These grants and awards contribute to our continuing investments in new technologies and research and development.
The majority of grants have been received from the Italian Ministry of Research (MIUR), the Italian Ministry of Productive Activities (MAP), the Italian Ministry of the Economy, the Lombardy Region of Italy, the Sardinia Region of Italy and the European Commission.
Italian Ministry of Research (MIUR) - Law 593/2000 art.10
Title: Drug discovery technologies
Start: September 2003
Lombardy Region-Metadistretti 2003
Title: Application of mouse embryonic stem cells in HTS
Start: January 2005
Lombardy Region-Metadistretti 2005
Title: Identification and characterization of chemokine receptors
Start: July 2006
Italian Ministry of Research (MIUR) and Sardinia Region - Law 593/2000 art.5
Title: Development of methodologies for the modelling and the study of biodrugs
Start: January 2006
Italian Ministry of the Economy and Sardinia Region - Bioinformatics Technologies applied to personalized medicine
Title: Bioinformatics Infrastructure applied to complex pathologies
Start: July 2006
Italian Ministry of Productive Activities (MAP) - Law 1982/46-Lombardy FIT
Title: Novel targets identification
Start: September 2004
European Commission – Sixth Framework Programme
Title: Development of clinical diagnostic tools in atherosclerosis (SOUTH)
Start: October 2006
European Commission – Sixth Framework Programme
Title: Production of innovative biomedical drugs (CONCO)
Start: February 2007
Research Collaborations
Axxam recognizes the contribution of scientific collaborations in extending our ability to develop innovative tools and technologies to improve assay performance and to identify novel and druggable targets in selected therapeutic areas, such as pain, osteoporosis and chronic obstructive pulmonary disease (COPD)/asthma.
This growing network of scientific and clinical partners forms an essential component of our discovery research process.
San Raffaele Scientific Institute, Milan, Italy
- Dr. Lawrence Wrabetz: Development of mouse embryonic stem cells for high-throughput
screening (HTS)
- Dr. Alessandro Rubinacci and Prof. Gianfranco Fraschini:
Identification
of novel targets in osteoporosis
San Raffaele University of Health Sciences, Milan, Italy
- Prof. Ruggero Pardi: Development of mouse embryonic stem cells for high-throughput
screening (HTS)
Dept. of Biotechnology and Bioscience, University of Milan Bicocca, Italy
- Prof. Enzo Wanke: Study of the function of membrane proteins
Dept. of Pharmacological Sciences, University of Milan, Italy
-
Prof. Maurizio Crestani: Study of metabolic regulation and metabolic disease
- Prof. Elena Cattaneo: Development of mouse embryonic stem cells for high-throughput
screening (HTS)
Dept. of Pharmacology, University of Florence, Italy
- Prof. Pierangelo Geppetti: Animal models of pain
Respiratory Pathophysiology Unit, Sesto San Giovanni Hospital,
Milan, Italy
-
Dr. Andrea Pelucchi: Identification of molecular targets for the
diagnosis and therapy of COPD
Rizzoli Orthopedic Institute, Bologna, Italy
-
Prof. Saverio Gnudi: Identification of novel targets in osteoporosis
Dept. of Clinical and Biological Sciences, University of Turin, Italy
-
Prof. Raffaele Calogero: Bioinformatic analyses and “data mining” from gene expression
analyses
Dept. of Chemistry, University of Naples, Italy
- Prof. Vincenzo Pavone: Molecular modelling of novel photoproteins
Institute of Biophysics, Russian Academy
of Sciences Siberian Branch
-
Dr. Eugene Vysotsky: Biochemical characterization of novel photoproteins
Monterey Bay Aquarium Research Institute, Monterey CA, USA
-
Dr. Steve Haddock: Isolation and characterization of fluorescent proteins in marine
organisms
National Human Genome Research Institute (NHGRI), Bethesda,
USA
-
Dr. Christopher Austin: Assay development and screening technologies
|
|
|
|
|
|
|
